{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:08:38Z","timestamp":1776272918319,"version":"3.50.1"},"reference-count":60,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Ulcerative colitis (UC) is associated with an elevated risk of colorectal cancer (CRC), driven by chronic inflammation and a distinct inflammation\u2013dysplasia\u2013carcinoma pathway. Conventional surveillance relies on colonoscopy and histologic assessment, but flat, multifocal dysplasia and sampling limitations challenge early detection. Tissue-based biomarkers offer promise in improving risk stratification and identifying patients at high risk for UC-associated CRC (UC-CRC). This review explores key categories of tissue biomarkers with potential clinical utility, including genetic mutations, epigenetic alterations, microRNA expression profiles, and markers of genomic instability such as telomere shortening, copy number variants, and aneuploidy. Many of these molecular alterations precede histologic dysplasia and reflect a \u201cfield effect,\u201d suggesting their potential role in early cancer detection. Despite compelling associations between these biomarkers and neoplastic progression, most lack prospective validation and are not yet ready for routine clinical use. Future research should prioritize the development of integrated biomarker panels and validate their predictive accuracy in longitudinal UC cohorts. Molecular profiling may ultimately enable personalized, risk-adapted surveillance strategies that improve early detection while minimizing unnecessary interventions.<\/jats:p>","DOI":"10.3390\/jcm14175979","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:09:53Z","timestamp":1756080593000},"page":"5979","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Biomarkers in Surveillance of Ulcerative Colitis-Associated Colorectal Cancer: A Scoping Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1046-6683","authenticated-orcid":false,"given":"Justin","family":"Kritzinger","sequence":"first","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gynter","family":"Kotrri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, McGill University, Montreal, QC H3G 2M1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3948-6488","authenticated-orcid":false,"given":"Peter L.","family":"Lakatos","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, McGill University, Montreal, QC H3G 2M1, Canada"},{"name":"Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2610-1910","authenticated-orcid":false,"given":"Talat","family":"Bessissow","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, McGill University, Montreal, QC H3G 2M1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9625-3437","authenticated-orcid":false,"given":"Gary","family":"Wild","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, McGill University, Montreal, QC H3G 2M1, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"103269","DOI":"10.1016\/j.eclinm.2025.103269","article-title":"Colorectal cancer risk in ulcerative colitis: An updated population-based systematic review and meta-analysis","volume":"84","author":"Zhang","year":"2025","journal-title":"eClinicalMedicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: An updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.suc.2017.01.010","article-title":"Dysplasia and Cancer in Inflammatory Bowel Disease","volume":"97","author":"Huang","year":"2017","journal-title":"Surg. Clin. N. Am."},{"key":"ref_5","first-page":"11","article-title":"Precancer in ulcerative colitis: The role of the field effect and its clinical implications","volume":"39","author":"Baker","year":"2018","journal-title":"Carcinogenesis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: A meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.3748\/wjg.v22.i35.7882","article-title":"Biomarkers for colitis-associated colorectal cancer","volume":"22","author":"Chen","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.3748\/wjg.v20.i22.6774","article-title":"Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis","volume":"20","author":"Scarpa","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00535-003-1258-9","article-title":"Efficacy of surveillance and molecular markers for detection of ulcerative colitis-associated colorectal neoplasia","volume":"38","author":"Fujii","year":"2003","journal-title":"J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s11894-999-0010-x","article-title":"Cancer surveillance in inflammatory bowel disease","volume":"1","author":"Bernstein","year":"1999","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.mog.0000231812.95525.a7","article-title":"Cancer surveillance in inflammatory bowel disease: New molecular approaches","volume":"22","author":"Risques","year":"2006","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Munn, Z., Peters, M.D.J., Stern, C., Tufanaru, C., McArthur, A., and Aromataris, E. (2018). Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med. Res. Methodol., 18.","DOI":"10.1186\/s12874-018-0611-x"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrgastro.2011.96","article-title":"Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis","volume":"8","author":"Thorsteinsdottir","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_15","first-page":"1447","article-title":"From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives","volume":"36","author":"Romano","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_16","first-page":"5927","article-title":"Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis","volume":"59","author":"Hisamatsu","year":"1999","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrgastro.2017.1","article-title":"Clonal evolution of colorectal cancer in IBD","volume":"14","author":"Choi","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PAP.0000000000000316","article-title":"The Significance of Flat\/Invisible Dysplasia and Nonconventional Dysplastic Subtypes in Inflammatory Bowel Disease: A Review of Their Morphologic, Clinicopathologic, and Molecular Characteristics","volume":"29","author":"Choi","year":"2022","journal-title":"Adv. Anat. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"22175","DOI":"10.18632\/oncotarget.14549","article-title":"KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: A meta-analysis","volume":"8","author":"Du","year":"2017","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.gtc.2006.07.002","article-title":"Molecular biology of dysplasia and cancer in inflammatory bowel disease","volume":"35","author":"Itzkowitz","year":"2006","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_22","first-page":"EC26","article-title":"Role of immunohistochemical expression of p53 in intestinal epithelial cells to detect dysplasia in patients with inflammatory bowel disease","volume":"16","author":"George","year":"2022","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/0016-5085(93)90639-T","article-title":"p53 point mutations in dysplastic and cancerous ulcerative colitis lesions","volume":"104","author":"Yin","year":"1993","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/0046-8177(94)90067-1","article-title":"p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma","volume":"25","author":"Harpaz","year":"1994","journal-title":"Hum. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0016-5085(94)90161-9","article-title":"Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis","volume":"107","author":"Brentnall","year":"1994","journal-title":"Gastroenterology"},{"key":"ref_26","first-page":"107","article-title":"Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia","volume":"22","author":"Fujii","year":"2003","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41379-020-00722-5","article-title":"Molecular characterization of ulcerative colitis-associated colorectal carcinomas","volume":"34","author":"Hirsch","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.2013.133","article-title":"Diagnostic utility of TP53 and cytokeratin 7 immunohistochemistry in idiopathic inflammatory bowel disease-associated neoplasia","volume":"27","author":"Xie","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2021.03.002","article-title":"Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia","volume":"112","author":"Singhi","year":"2021","journal-title":"Hum. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/gastro\/gov022","article-title":"Overexpression of p53 predicts colorectal neoplasia risk in patients with inflammatory bowel disease and mucosa changes indefinite for dysplasia","volume":"3","author":"Horvath","year":"2015","journal-title":"Gastroenterol. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13402-010-0006-4","article-title":"Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: A case-control study","volume":"34","author":"Gerrits","year":"2011","journal-title":"Cell. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1080\/003655201317097191","article-title":"Comparison of flow cytometry and histology with mutational screening for p53 and Kiras mutations in surveillance of patients with long-standing ulcerative colitis","volume":"36","author":"Holzmann","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000111482","article-title":"Limits of diagnosis and molecular markers for early detection of ulcerative colitis-associated colorectal neoplasia","volume":"77","author":"Fujii","year":"2008","journal-title":"Digestion"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00042737-200210000-00005","article-title":"Screening for p53 and K-ras mutations in whole-gut lavage in chronic inflammatory bowel disease","volume":"14","author":"Heinzlmann","year":"2002","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/MIB.0000000000000795","article-title":"DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn\u2019s Colitis: Implications for Surveillance","volume":"22","author":"Johnson","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/10350-007-0302-x","article-title":"Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis","volume":"50","author":"Moriyama","year":"2007","journal-title":"Dis. Colon. Rectum"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s10620-014-3193-4","article-title":"DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis","volume":"59","author":"Ueda","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.MIB.0000435443.07237.ed","article-title":"FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia","volume":"20","author":"Papadia","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"vi118","DOI":"10.1093\/annonc\/mdz343","article-title":"P1-001\u2014MicroRNA-9 methylation reflect epigenetic drift and identify patients with risk for C-associated colorectal neoplasia","volume":"30","author":"Okugawa","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ebiom.2018.11.034","article-title":"Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study","volume":"39","author":"Beggs","year":"2019","journal-title":"eBioMedicine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000341882","article-title":"MicroRNAs and inflammation in the pathogenesis and progression of colon cancer","volume":"30","author":"Okayama","year":"2012","journal-title":"Dig. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S1995-7645(13)60174-1","article-title":"Screening of differentially expressed microRNA in ulcerative colitis related colorectal cancer","volume":"6","author":"Tan","year":"2013","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"i540","DOI":"10.1093\/ecco-jcc\/jjad212.0345","article-title":"P215 Mir-135b, an Early Biomarker of Sporadic and IBD-Related Colorectal Carcinogenetic Progression","volume":"18","author":"Barberio","year":"2024","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20709","DOI":"10.18632\/oncotarget.25065","article-title":"Increased mucosal expression of miR-215 precedes the development of neoplasia in patients with long-standing ulcerative colitis","volume":"9","author":"Pekow","year":"2018","journal-title":"Oncotarget"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/humu.22021","article-title":"Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer","volume":"33","author":"Kanaan","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2741\/e514","article-title":"miRNAs are stable in colorectal cancer archival tissue blocks","volume":"4","author":"Bovell","year":"2012","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1097\/MIB.0b013e3182a87640","article-title":"Clonal expansions and short telomeres are associated with neoplasia in early-onset, but not late-onset, ulcerative colitis","volume":"19","author":"Salk","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Shivakumar, B.M., Chakrabarty, S., Rotti, H., Seenappa, V., Rao, L., Geetha, V., Tantry, B.V., Kini, H., Dharamsi, R., and Pai, C.G. (2016). Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2303-4"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/bjc.1991.302","article-title":"Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis","volume":"64","author":"Meling","year":"1991","journal-title":"Br. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0016-5085(92)91185-7","article-title":"DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis","volume":"103","author":"Rubin","year":"1992","journal-title":"Gastroenterology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/gut.28.9.1100","article-title":"Flow cytometric DNA analysis in longstanding ulcerative colitis: A method of prediction of dysplasia and carcinoma development?","volume":"28","author":"Tribukait","year":"1987","journal-title":"Gut"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/bs.acr.2021.03.004","article-title":"Field carcinogenesis for risk stratification of colorectal cancer","volume":"151","author":"Rebello","year":"2021","journal-title":"Adv. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Reznicek, E., Arfeen, M., Shen, B., and Ghouri, Y.A. (2021). Colorectal Dysplasia and Cancer Surveillance in Ulcerative Colitis. Diseases, 9.","DOI":"10.3390\/diseases9040086"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"East, J.E., Gordon, M., Nigam, G.B., Sinopoulou, V., Bateman, A.C., Din, S., Iacucci, M., Kabir, M., Lamb, C.A., and Wilson, A. (2025). British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease. Gut.","DOI":"10.1136\/gutjnl-2025-335023"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","article-title":"ECCO Guidelines on Inflammatory Bowel Disease and Malignancies","volume":"17","author":"Gordon","year":"2023","journal-title":"J. Crohns Colitis"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.cgh.2016.11.021","article-title":"Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn\u2019s Disease: A Systematic Review of Randomized Trials","volume":"15","author":"Iannone","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0016-5107(00)70405-6","article-title":"How gastroenterologists screen for colonic cancer in ulcerative colitis: An analysis of performance","volume":"51","author":"Eaden","year":"2000","journal-title":"Gastrointest. Endosc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gutjnl-2024-333353","article-title":"Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis","volume":"74","author":"Curtius","year":"2025","journal-title":"Gut"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer current: Status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/17\/5979\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:07Z","timestamp":1760034907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/17\/5979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":60,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14175979"],"URL":"https:\/\/doi.org\/10.3390\/jcm14175979","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]}}}